• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

MBI taps Venkatadri as CEO

Article

Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and

Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and corporate development activities. Venkatadri's promotion culminated a succession plan agreed upon when he was hired in November 1995, according to the San Diego-based company.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.